HomeMarkets Markets Crispr Surges After Winning The First CRISPR Gene-Editing Approval By news November 16, 2023 0 135 FacebookTwitterPinterestWhatsApp In a world first, regulators in the U.K. approved Crispr Therapeutics’ (CRSP) gene-editing treatment for two blood diseases on Thursday. CRSP stock …This post was originally published on this site Share FacebookTwitterPinterestWhatsApp Subscribe Login Notify of new follow-up comments new replies to my comments Please login to comment 0 Comments Inline Feedbacks View all comments Stay Connected157,969FansLike396,312FollowersFollow2,240SubscribersSubscribe Latest Articles Markets U.S. economy was hotter than previously thought, new GDP data shows Markets Okta Data Breach Affects All Customer Support Support Clients Markets Weak Dollar Wednesday – Rate Cut Bets and Chinese Stimulus (again) Markets The militarized AI risk that’s bigger than “killer robots” Markets AWS unveils ‘Amazon Q’ AI assistant, jabs at Microsoft and OpenAI at re:Invent Load more